M33 - Managing Iron Supplementation - State of the Science (M33)

LEARNING OBJECTIVES

1. Increase knowledge on hemoatopoiesis and the impact on iron status
2. Enhance understanding of iron physiology and the mechanisms to maintain iron homeostasis
3. Identify new iron formulations and indications for use in clinical practice including children and adults
4. Identify pros and cons on iron formulation in clinical care using a debate format

FACULTY AND TOPICS
Overview of Hematopoiesis: Focusing on Iron Regulation
Amanda Jacobson-Kelly, MD, MSc, Assistant Professor of Pediatrics, Division of Hematology, Nationwide Children’s Hospital/The Ohio State University College of Medicine, Columbus, OH

Overview of Oral Iron Absorption and Kinetics
Lingtak-Neander Chan, PharmD, BCNSP, FCCP, FACN, Professor and Associate Chair, Department of Pharmacy; Interdisciplinary Faculty, Nutritional Sciences Program, University of Washington, Seattle, WA

Recent Advances in Iron Formulations
Kyle Hampson, PharmD, BCNSP, BCPPS, CNSC, Assistant Professor of Pharmacy Practice; Clinical Pharmacy Educator, Pediatrics and Nutrition Support, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY

MODERATOR
Lingtak-Neander Chan, PharmD, BCNSP, FCCP, FACN

This session includes pediatric content